Mostra el registre parcial de l'element
dc.contributor.author | Belarte Tornero, Laia Carla |
dc.contributor.author | Mojón Álvarez, Diana |
dc.contributor.author | Solé-González, Eduard |
dc.contributor.author | Ruiz-Bustillo, Sonia |
dc.contributor.author | Valdivielso Moré, Sandra |
dc.contributor.author | Farré López, Núria |
dc.date.accessioned | 2022-06-29T06:10:27Z |
dc.date.issued | 2021 |
dc.identifier.citation | Belarte-Tornero LC, Mojón D, Solé-González E, Ruiz-Bustillo S, Valdivielso-More S, Farré N. Sacubitril-valsartan modifies the indication of cardiac implantable devices in patients with heart failure and reduced ejection fraction. Rev Esp Cardiol (Engl Ed). 2021 Dec;74(12):1117-9. DOI: 10.1016/j.rec.2021.06.005 |
dc.identifier.issn | 1885-5857 |
dc.identifier.uri | http://hdl.handle.net/10230/53629 |
dc.format.mimetype | application/pdf |
dc.language.iso | eng |
dc.publisher | Elsevier |
dc.relation.ispartof | Rev Esp Cardiol (Engl Ed). 2021 Dec;74(12):1117-9 |
dc.rights | © Elsevier http://dx.doi.org/10.1016/j.rec.2021.06.005 |
dc.title | Sacubitril-valsartan modifies the indication of cardiac implantable devices in patients with heart failure and reduced ejection fraction |
dc.title.alternative | El sacubitrilo-valsartán modifica la indicación de dispositivos implantables en pacientes con insuficiencia cardiaca y fracción de eyección reducida |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | http://dx.doi.org/10.1016/j.rec.2021.06.005 |
dc.rights.accessRights | info:eu-repo/semantics/openAccess |
dc.type.version | info:eu-repo/semantics/acceptedVersion |